Healthcare Press Releases

Retired professional hockey player, Marvin Degon IV and the Athletes for CARE team hit the ice on Sunday

FORT MYERS , FLA. , UNITED STATES , August 20, 2018 /EINPresswire.com/ — Retired professional hockey player, Marvin Degon IV, a Naples, Florida resident, participated in the Hockey Summit Pro All-Star Tournament on Sunday at the Fort Myers Skatium Arena to benefit charity.

Degon, who now serves as director of athletics for VEDA Endocannabinoid Nutrition, laced up his skates Sunday for the summit’s 3×3 all-star tournament with proceeds benefiting Athletes for CARE, a 501(c)3 non-profit organization.

The Hockey Summit is an off-season training platform designed to provide the most comprehensive training environment for professional hockey players all under one roof.

“Using the most advanced training technology, DNA nutritional testing, on ice video teaching methods, and recovery techniques, we leave nothing to chance in ensuring every individual need is addressed and developed to improve performance and prolong careers for our athletes.” said, Justin Roethlingshoefer, the strength and conditioning coach for the Anaheim Ducks and co founder of the program with Everblades great Ernie Hartlieb.

The Hockey Summit worked with Athletes For Care to put together The Pro Week Weekend as an extended benefit to the athletes and the communities where they play.

“We are dedicated to creating a community where athletes can find support, opportunity and purpose in life after a career in sports so teaming up with Justin and Ernie made perfect sense.” said Riley Cote, founder of Athletes for CARE.

Athletes For CARE is the first-of-its-kind in professional sports. The non-profit serves as a global advocacy and support organization created by athletes for athletes. Their mission is to raise awareness for critical health and safety issues that impact athletes of all ages and promote solutions that lead to a better quality of life.

Degon, a veteran professional hockey player with a 10 year career, knows firsthand how having access to cutting edge support systems can benefit an athlete’s success rate. He is also familiar with the struggles that can come after retirement.

“I’m excited to educate athletes on life after the sport and the nutritional alternatives that are both natural and sustainable to help them deal with the toll taken on their bodies as athletes at the professional level,” said Degon. “Athletes for Care has led the way and introduced the conversation of cannabis and hemp products into the athletic world. I’m excited be a part of the continued movement and assist in providing an educational platform.”

About VEDA:
VEDA was founded by a unique group of experts in agricultural science, chemistry, biology, healthcare, and finance. VEDA has been developed to address the overwhelming deficiency in Endocannabinoid Nutrition (ECN) that affects the health and well-being of individuals all over the world.

VEDA products are formulated to provide the highest bioavailability, the most effective delivery systems and to ensure customer accessibility and affordability. Driven by principles and quality, at VEDA we are dedicated to having a profound impact on humanity. We believe everyone should have access to quality ECN to enhance health.

VEDA provides a variety of ECN products including; tincture, spray and vape. The VEDA Active line is set to launch Fall 2018.

VEDA ECN is a subsidiary of Avant Garde Holdings Americas, Inc., dba AG Health, a research and development company of bio-pharmaceutical products, big data analytics, health information and disease management, drug formulations and commerce solutions for the U.S. cannabis and hemp industry.

For more information on AGH, visit the company’s website at https://avantgardeholdings.net

James Judge
Judge Public Relations
813.279.8335
email us here

Source: EIN Presswire

2018 Inc. 500|5000 List ranks ProScribe as the 1,610th fastest-growing private company in America with a 289% growth over the last three years.

SAN ANTONIO, TEXAS, UNITED STATES, August 20, 2018 /EINPresswire.com/ — ProScribe has been recognized as the nation’s 1,610th fastest-growing private company in America by Inc. Magazine’s 500|5000 list.

ProScribe is a full-service in-person and virtual medical scribe vendor that was founded in 2010 to offset the burden of Electronic Health Record (EHR) documentation requirements. Provider burnout is at an all-time high due to EHR requirements and as a result, providers are spending less time interacting with their patients and more time entering data into their EHR.

ProScribe enables healthcare providers to put their focus back on their patients and boost their productivity while decreasing burnout. They specialize in recruiting, hiring, and training medical scribes to document into the EHR on behalf of the provider.

With over 1900 medical scribes operating across the nation, ProScribe is the recognized leader in providing the best-trained medical scribes and the most reliable shift coverage in the industry. For the past two years, they have covered 99.8% of all contracted shifts. Furthermore, ProScribe delivers these outstanding services at cost-effective rates.

“I want to congratulate every ProScribe employee that contributed to this outstanding achievement. We have always put our clients first, which is reflected in our outstanding client retention rate. We expect exponential growth over the next 3 years as more health systems recognize the benefits we offer to their providers and as we continue to convert other underperforming scribe programs to ProScribe.” – Toby Mulligan, CEO of ProScribe.

ProScribe utilizes a turnkey program model to provide specialized medical scribe programs for an array of healthcare providers in clinics, healthcare systems, and hospitals from coast to coast.

ProScribe’s success is based on creating true partnerships and providing the highest quality medical scribes, reliable coverage and responsive customer service. They credit their success to their corporate team who puts the care of their customers and employees above all else. ProScribe is excited about the future growth of the company and improving the quality of healthcare in the United States.

About ProScribe

ProScribe is one of the nation’s fastest-growing providers of in-person and virtual medical scribe services. Our innovative recruitment, training and quality assurance programs have successfully proven to increase physician productivity, patient satisfaction and improve physicians’ quality of life in a wide variety of practice settings.

Toby Mulligan
ProScribe
210-545-2500
email us here

Source: EIN Presswire

Bret Brummitt

AGIA Partner and Senior Consultant Bret Brummitt recognized for his expertise with employee benefit strategies, insurance education, and human resource support.

FORT WORTH, TEXAS, UNITED STATES, August 20, 2018 /EINPresswire.com/ — AG Insurance Agencies is proud to announce that Partner and Senior Consultant Bret Brummitt has been awarded the prestigious CEO Today Magazine Healthcare Award 2018. “Bret has been excellent to work with. His knowledge and expertise provide remarkable confidence in making the right decisions regarding benefits for our employees. Our company has grown since we started working with Bret and he has anticipated our needs and provided the best resources and options for our company at every stage. One of the best decisions I’ve made was to work with Bret!” shared Brad Cecil, Founder and President of Brad Cecil & Associates and one of Bret’s many happy clients.

Based in England, CEO Today Magazine is an international publication dedicated to providing CEOs and C-level executives with the latest corporate developments, business news and technological innovations. According to CEO Today Magazine, their team identifies and honors the most respected executives who lead the way on a global stage. Their annual awards continue to reward and celebrate the leadership and strategic vision of executives across a number of sectors, such as healthcare, to identify the most successful, innovative and forward-thinking executives in business today.

Healthcare Award nominations were open worldwide to the entire readership of CEO Today and all C-level executives, business owners, consultants, entrepreneurs and those operating within the healthcare space. Researchers at CEO Today determined the eventual winners based on the nomination data received and the achievements of individual consultants. Achievements were defined and scored upon the following criteria: involvement in significant performance improvements, expansion into new markets, recognized results achieved for shareholders and patients, innovation in patient care, innovative products and services development, performance improvement of existing services, procedures and pharmaceuticals, new medicines/services, new business model, and strategy.

Bret Brummitt has exhibited many of these criteria in his roles at AG Insurance Agencies, Inc. for almost 19 years. He specializes in employee benefit strategies, insurance education, employee communication, budget forecasting, data analysis, technology evaluation, human resource support and payroll integration. His skillset and passion for problem solving are just a subset of characteristics that make him successful. In his own words, he is a “doer, deep thinker, fixer of health plans.” Bret is humbled and grateful for this esteemed recognition from CEO Today Magazine, “My career at A.G. Insurance has been an amazing journey that has allowed me to grow and develop not only technically and strategically within the realm of benefits consulting, but it has been a privilege to be trusted with a leadership role at the same time. My greatest pleasure is watching the development of our team and seeing them become the champions of change when they identify a recurring problem for our clients that we can collaboratively fix.”

Lian Loop
The Brummitt Group
(214) 295-6130
email us here

Source: EIN Presswire

Beth Reimer to Senior Audit Manager

Carly Roberts to Manager CFO Services

Dan Schaffer to Senior Accountant

Kathleen Moran to Senior Tax Manager

Matt Migal to Manager

"On behalf of the firm, we would like to congratulate the following team members on their recent promotions." Tina Moore, Director of Human Resources

CLEVELAND , OHIO, UNITED STATES, August 20, 2018 /EINPresswire.com/ — Pease & Associates CPAs would like to announce the following team members as they continue to thrive and grow:

– Beth Reimer to Senior Audit Manager
– Carly Roberts to Manager CFO Services
– Dan Schaffer to Senior Accountant
– Kathleen Moran to Senior Tax Manager
– Matt Migal to Manager

About Us:

Choose Pease & Associates, CPAs as your Cleveland CPA Firm
Pease & Associates, CPAs has been proudly serving the Cleveland area as a CPA firm for more than 15 years. As we’ve grown to have more than 80 employees, we still provide the same exceptional quality of service and customer support that has separated us from the start.

We seek to exceed your expectations, while providing honest, dependable tax, audit, and estate planning services. When you don’t know where to turn to find a CPA, you want to choose a reputable company, one you can trust, and one with the firsthand experience you or your business needs.

As opposed to many CPAs, our firm has a more streamlined focus, enabling us to offer you truly specialized, expert assistance. Our CPA company handles tax services, auditing and assurance, business consulting, and estate planning, with a proven track record of expertise.

We have three local offices in Cleveland, Akron and Beachwood, Ohio. Call us at 216.348.9600 or visit www.peasecpa.com to learn more about how we can help, and why you can always be confident in choosing Pease & Associates, CPAs as your CPA firm.

Tina Moore
Pease & Associates CPAs
216-348-1600
email us here

Source: EIN Presswire

Eyebrow and Eyelid Lift by Plasma Pen Pro (PPP)

Plasma Pen Pro and Plamere Plasma Pen Training Program in the USA

Plasma Pen eyelid lift and under eye lift by rose cruz

Plasma Pen Pro are bringing the latest in Plasma Fibroblast training and certification to the USA using the latest equipment and techniques available today.

SAN FRANCISCO, CALIFORNIA, USA, August 20, 2018 /EINPresswire.com/ — Fighting the effects of aging or too much stress or sun on the skin can be quite a challenge. The good news is the latest in beauty skin treatments using a plasma fibroblast pen can have dramatically positive effects when delivered by a skilled technician. The good news for North Americans is the worldwide leader in Plasma Fibroblast Training and Certification Rose Cruz and Plasma Pen Pro will be making a number of teaching and certification dates in the USA starting November 2018, opening the door to learning and being able to perform a much-in-demand beauty technique. This can be a valuable skill in a very competitive industry.

“Plasma Pen certification changes many lives for the better,” remarked Cruz. “Plasma Pen Pro has made it as easy as possible to learn the method and to begin being able to personally help clients after being certified by us. We are really looking forward to our hands-on USA teaching events.”

The Plasma Pen Fibroblast treatments work by creating an electric charge, called an ARC, that is focused on the surface of the skin. It then uses this to create a controlled burn, or carbonization of the skin, which leads to skin tightening, wrinkle removal or reduction, scar reduction, tummy tucks, as well as, remove skin tags, warts, blemishes, and just overall make skin seem more vibrant and youthful.

The entire process is safe, in the hands of a trained PPP professional, and requires no surgery and only 5-7 days of social downtime. Rose Cruz and Plasma Pen Pro have been recognized as the “best-of-the-best” in the training and certification of this exciting method.

Rose Cruz and Plasma Pen Professionals (PPP) group have trained students from around the world, and are now taking their highly regarded PPP Training and Certification program to the world, starting with the USA this November 2018 in San Francisco, California. Other dates and locations include Las Vegas, Detroit, Orlando, Charlotte, and many more to be listed on their www.plasmapenpro.com website.

The cost of the program is $4250USD, and includes: Plamere Plasma Pen, Training, Live Model Training, Manual, PPP KIT. This system has contains everything a student needs in order to start working immediately after they receive their Plasma Pen Pro Certification.

Plasma Pen Professionals (PPP) will be using the FDA approved Plamere Plasma Pen to teach and train the future PPP professionals in this art. “It may seem as though we are just placing dots on the face randomly and sporadically, but there is an art and a science to dot placement, in order to get the results we are looking for” says Rose Cruz, who has been in the beauty industry for over 25 years. “We’ve trained hundreds of students from around the globe, and there are still millions more techs that don’t even know this treatment exists, and millions of potential clients that don’t know this alternative treatment to botox and surgical facelifts is even an option”.

Most beauticians in the industry charge between $500 – $3000 per treatment, depending on the area being treated, and most technicians make between $10,000 and $25,000 per month, depending on their workload.

Plasma Pen Professionals (PPP) are the global leaders in the Plasma Fibroblast industry for one reason – their ability to train others in the proper technique of PPP. Students that leave the training program, usually leave as professionals in the industry, confident that they can perform these treatments in their own office, on their own clients, and manage to get the same or similar results as those obtained by Plasma Pen Professionals.

For more info about the Plasma Pen training program, please visit www.plasmapenpro.com.

For more pictures and videos of actual real PPP clients and students work, please visit www.instagram.com/plasmapenpro

To register for the PPP San Francisco course, please visit: https://www.plasmapenpro.com/events/ppp-training-and-certification-san-francisco-ca-nov-4-5-1

Our San Francisco PPP Training program is being held at Infinite Beauty Studio, by Natalia Bartrom.

Recent feedback from students has been very encouraging.

Shawna T., from Toronto, Ontario, commented in a five-star review, “I was having a great deal of trouble getting hired at a local beautician until I became Plasma Pen Pro certified and was able to show them how this new service would help bring in more customers. Ever since then my life has been really great. Thank you, Rose Cruz!”

For more Plasma Pen Reviews, please visit: https://goo.gl/Q8xXwg

For more information, be sure to visit https://www.plasmapenpro.com.

Rose Cruz
Plasma Pen Pro
4164817546
email us here

Plasma Pen Pro Plamere Non-Surgical Eyelid Lift

Source: EIN Presswire

ROCKVILLE, MD, UNITED STATES, August 20, 2018 /EINPresswire.com/ — American Gene Technologies International Inc. (AGT)’s CEO and founder Jeff Galvin has been appointed to the Board of Directors of the Maryland Tech Council, the largest Maryland technology trade association, representing over 600 companies across the breadth of technology and life science industries.

Galvin stated: “I am honored to contribute to the tremendous impact Maryland Tech Council is making in the state. It is an important enabler for biotech and technology — two industries that have huge potential economic impact for the state. It’s been a great experience to be a member for these past years, the Maryland Tech Council has made a positive impact on AGT. I see this appointment as an opportunity to give back to the important work Tami Howie and her team are doing to help build strong technology and life science companies in Maryland."

Galvin earned his BA degree in Economics from Harvard in 1981. He has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies.

Galvin is a veteran member of the Maryland Tech Council and has been involved in its recent progress. He participated in various activities with the Maryland Tech Council, including: jointly testifying before the Maryland Senate Finance Committee against generic drug price control legislation that could curtail Marylander’s access to drugs (SB1023); participating as a featured member at Maryland Tech Council's BIO International Conference; and sponsoring or participating in its other events, such as TEDCO’s Innovation Challenge, MTC Industry Awards, East Coast VentureCON, and the Bio+Tech18 Conference.

Tami Howie, CEO of Maryland Tech Council, announced: “As a 12-year veteran in the biotech industry in Maryland having decades of experience in Silicon Valley in the tech industry, we are excited to have Jeff Galvin join our Board of Directors. His strong experience and success in both tech and biotech will be instrumental to the work we do to foster a healthy biotech and technology ecosystem in Maryland. His mission and experience are closely linked to what we are creating in Maryland and we see his participation as an asset for the Council.”

Howie is a key opinion leader in Maryland’s biotech and technology industries. For the past 20 years, Howie has helped technology companies grow in the Mid-Atlantic region and nationwide. She has been involved with the successful exits of over 150 companies and has represented technology companies, investors, SBICs and underwriters such as JP Morgan, Goldman Sachs and Morgan Stanley. Howie and Galvin share a common passion for developing the tremendous potential of the biotechnology and technology industries in Maryland to dramatically increase the economy and business ecosystem. Maryland Tech Council published the following press release announcing 2018 appointments to the board: http://bit.ly/2OK3zsC

About American Gene Technologies (AGT):

AGT is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including large and orphan indications, infectious diseases, immune-oncology, and monogenic disorders. AGT expects to take its patented, lead candidate for an HIV Cure into the clinic in 2019. It has pioneered a novel immuno-oncology approach of stimulating gamma-delta (γδ) T cells to attack a variety of cancers. Four key patents in AGT’s novel immuno-oncology approach have been granted. AGT has a diverse portfolio of patent filings surrounding key tools and components in viral vectors, gene therapy, and regenerative medicine.

Website: https://www.americangene.com/

American Gene Technologies Contact:

C. Neil Lyons, Chief Financial Officer
Phone: (301) 337-2269
Email: info@americangene.com

Company Social Media:

LinkedIn – https://www.linkedin.com/company/american-gene-technologies-international-inc/
Twitter – @americangene, https://twitter.com/americangene
Facebook – @amerigene, https://www.facebook.com/amerigene/
Instagram – @americangenetechnologies, https://www.instagram.com/americangenetechnologies/

Media Contact: Sasha Whitaker
American Gene Technologies
(301) 337-2269
email us here

Source: EIN Presswire

Real-World Protection Test AV-Comparatives July 2018

Tested Products by AV-Comparatives

Logo AV-Comparatives

AV-C's Real-World Protection Test is currently the most comprehensive and complex test available, using a large number of test cases.

INNSBRUCK, TYROL, AUSTRIA, August 20, 2018 /EINPresswire.com/ — AV-Comparatives' Real-World Protection Test is currently the most comprehensive and complex test available, using a large number of test cases. Currently, we are running this test under Microsoft Windows 10 Pro RS4 64 Bit with up-to-date third-party software (such as Adobe Flash, Adobe Acrobat Reader, Java, etc.). Due to this, finding in-the-field working exploits and running malware is much more challenging than e.g. under an non-up-to-date system with unpatched/vulnerable third-party applications.

This fact sheet is a short overview of the Whole-Product Dynamic Real-World Protection Test results of July 2018. The detailed overall result consumer product reports (covering five months each) are released in July and December. Each of the overall result reports will also contain a false-alarm test and will contain the awards the products reached based on their overall scores during the respective five-month period. For more information about this Real-World Protection Test, please read the detailed factsheet.

https://www.av-comparatives.org/tests/real-world-protection-test-july-2018-factsheet/

Testcases
Over the year we evaluate several tens of thousands malicious URLs. Unfortunately, many of these have to be discarded for various reasons. We remove duplicates such as the same malware hosted on different domains or IP addresses, sites already tested, “grey” or non-malicious sites/files, and malware/sites disappearing during the test. Many malicious URLs carrying exploits were not able to compromise the chosen system/applications because of the patch level. This means that the vulnerabilities in the third-party applications on the system were already patched and the exploits could therefore not deliver their malicious payload. Users should be aware that by always keeping their system and third-party applications up-to-date/patched, they can dramatically decrease the risk posed by exploits.

Test Results
The results are based on the test set of 186 live test cases (malicious URLs found in the field), consisting of working exploits (i.e. drive-by downloads) and URLs pointing directly to malware. Thus exactly the same infection vectors are used as a typical user would experience in everyday life. The test-cases used cover a wide range of current malicious sites and provide insights into the protection given by the various products (using all their protection features) while surfing the web.

Every month (from February to June and from July to November) we update the charts on our website showing the protection rates of the various tested products over the various months. The interactive charts can be found on our website. The chart below shows only the protection scores for the month of JULY 2018 (186 test cases). The results of the false-positives test are also shown in the monthly factsheets/graph.

Mediacontact
AV-Comparatives
+43720115542
email us here

Source: EIN Presswire

SEATTLE, WASHINGTON, UNITED STATES, August 20, 2018 /EINPresswire.com/ — To live from a higher vibration means not only to live more authentically, but to follow your inner guidance and intuition completely. This creates an enticing life of joy and wonder where your highest self is invited to emerge!

Januarie Wood Is a HiVibe practitioner, clairvoyant, and international speaker. She offers individual mentoring programs, corporate trainings, classes and talks, Energy Readings, and MindMeditations.

“It's learning how to be embodied, authentic, fully present,” says Januarie. “It's time for us to connect to our core purpose of why we came into this earth and our core connection to one another.”

Januarie has appeared on ACB, NBC, FOX, and CBS news programs and has been featured in 417 Magazine, local Business Journals, Today’s Woman, and various publications for her work in stress management, weight release and related topics.

“Everything I offer is about raising your vibration and allowing you to express your soul's truest purpose,” explains Januarie. Clients are people from all walks of life who need a shift in their lives. They feel it, but they’re not sure what to do next.

Januarie’s has spoken for Wichita State University, Cal Poly University, Justice Jewelers, Los Angeles Circuit Courts, Kansas City School Board, Fort Belvoir, and various other companies in the States and internationally.

Individual clients come away with a deeper sense of purpose, more peace and clarity and much less stress. And they have a set of tools and exercises they can continue to use on their own.

Groups and teams come away with a sense of their own motivations and ways of operating and how to become more genuine and effective. They learn how to engage with others on a higher level and how to use their Intuitive Intelligence to create peace and flow in their organizations.

“The bigger picture is this: We must learn to trust our inner knowing and engage our brains less. This leads us to less stress and struggle and abundant joy and purpose. It’s time to surrender to a better way of operating – That’s HiVibe Living.”

CUTV News Radio will feature Januarie Wood in an interview with Doug Llewelyn on August 22nd at 1pm EDT.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Januarie Wood, visit www.januarie.net

Lou Ceparano
CUTV News
(631) 850-3314
email us here

Source: EIN Presswire

CALGARY, ALBERTA, CANADA, August 20, 2018 /EINPresswire.com/ — Psychologist Valerie Kendall, or Dr. Val as she is familiarly known, is an MA, PhD, Registered Therapist with numerous other credentials in her arsenal. She also practices a full complement of modalities, and for clients of all ages. As a certified Play Therapist in both Canada and the U.S.A., she works a lot with children through the medium of play. With many adults she counsels in the field of ADD or addictive behaviors, which include sex addiction, gambling, and The Internet. Regarded as a Substance Abuse Expert, she assesses and counsels people on the abuse of alcohol and drugs. With other adults, she functions as a couples’ counselor. Above all, she is someone who cares, who builds a true relationship with clients and offers the kind of unconditional love that lets them know that even when they feel they are at the most unlovable point in their lives, they still have value.

Dr. Val practices out of two localities 1) The Healing Space, Calgary, and 2) McRae St. Okotoks. She is affiliated with many professional associations in Canada including: CPA, PAA, CCPA, CFCH, (AB.), ACEP. She’s registered and certified with the American Board of Hypnotherapy and the Alberta Hypnotherapy Association. Dr. Val attends workshops and conferences offered by the Rocky Mountain Play Therapy Institute, where she did most of her child therapy training. This led to an invitation to write a chapter in the forthcoming book Turning Points in Play Therapy and The Emergence of Self. Her section recounts one case history that professionals and families will learn from, about when a child in play therapy reveals that first glimmer of hope and progress.

While some of Dr. Val’s therapies correlate to energy and that might seem edgy, she felt that if so many PhDs were involved in an organization like ACEP (Association for Comprehensive Energy Psychology), it must be worth investigating. Depending on the client, their interest and mindset, she might use a newer technique like EFT or a more conventional approach like cognitive behavioral therapy When she does apply Emotional Freedom Technique, she’ll introduce the concept of energy flow and tell clients energy is something that exists, but we don’t see it travelling across the air – like the key fob that opens a car door or a cell phone text message. This energy is inside us too, and Dr. Val might tap on acupressure points in the body to release it and rebalance the body.

Dr. Val has lived in England and Canada and was in the education field before she became a therapist, as a resource room teacher and sports coach. She believes the one-to-one rapport she used with students is what helps her reach children today, and to create a sense of respect for people of any age. Being genuine, having positive regard, establishing trust, and empathy for the client are some elements of Carl Rogers’ person-centered approach that inspire congruence with patients. This Carl’s emphasis on the relationship revolutionized the American Psychological approach, which at the time emphasized psychodynamic and behaviorist method. It makes him one of Dr. Val’s idols. Another Carl that influenced her was Carl Jung. She embraces many of his concepts, such as archetypes (inborn tendencies resonating and driving basic human behavior), and his sense of connectedness across our big world– like when a butterfly flaps its wings in Japan and it is felt elsewhere.

Dr. Val says some techniques that work with children can also break through to adults. Someone might be nervous about opening up to a therapist, but when you toss them a ball, or hand them a musical instrument, it’s not formal or intimidating anymore. Still, she has to tell clients things they don’t want to hear, like own up to the consequences of an impulsive choice or negative behavior, or it’s to go off to rehab. She may have to be tough at times, but for the most part she likes to have fun, and loves bringing about change.

CUTV News will feature Dr. Valerie Kendall in an interview with Jim Masters on Wed, Aug 22 at 4:00pm EDT

Listen to the show on BlogTalkRadio

If you have questions for our guest, please call (347)996-3369

Lou Ceparano
CUTV News
(631) 850-3314
email us here

Source: EIN Presswire

Preliminary Analysis Demonstrates CSS Device Has To Date Exceeded Expectations for Specificity and Sensitivity Compared to Duplex Doppler Ultrasound

CVR Medical Corp (TSX:CVM.V)

VANCOUVER, BRITISH COLUMBIA, CANADA, August 20, 2018 /EINPresswire.com/ — VANCOUVER, BC / August 20th, 2018 / CVR Medical Corp. (CVM.V) (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical”) a Canadian listed and US based healthcare company in the medical device sector announces advisory staff member Dr. Phillip J. Bendick, PhD, has released an internal report summarizing data from the pivotal clinical trials for the Carotid Stenotic Scan (CSS) devices in use at Thomas Jefferson University Hospital. In alignment with the previous report released by Dr. Bendick in September 2017, this preliminary report views the initial batch of data points collected within the trial as successful for the substantiation of the device’s value and efficacy. Though only a partial snapshot of the data (with the trial ongoing), the improvements made to the CSS prior to launch of the pivotal clinical trials has generated enhanced functionality within the clinical setting.

The CSS Device is being evaluated in a multi-center pivotal clinical trial to evaluate the system’s specificity and sensitivity for detecting carotid artery disease, compared to the current gold standard – duplex Doppler ultrasound.

Dr. Bendick states, “The early results of the first 144 patients enrolled in the CSS pivotal trial have shown excellent overall accuracy […] these initial results demonstrate the efficacy of the CSS as a tool to detect and guide the appropriate management of clinically important carotid artery disease in order to reduce stroke risk.”

“This report further validates the advancements implemented by CVR prior to the launch of our pivotal trials,” said Peter Bakema, CVR CEO. “All along we have aimed to arm the clinician with a tool that is not only accurate, but seamlessly translates to improved care for his or her patients. Every aspect of the CSS, from the user interface to the streamlined cart, embodies this principle. This preliminary report reinforces our previously stated commitment to deliver a product with greater than 85% sensitivity level.”

Additionally, due to the current extended lead time for mandatory electrical safety testing, CVR has extended its anticipated CSS FDA submission target to October 2018.

Carotid Stenotic Scan Pivotal Trial Internal Data Analysis: Data Summary with Patient Edits*
By: Phillip J. Bendick, PhD

Location: Thomas Jefferson University Hospital
Primary Investigator: Dr. David Whellan

Number of Samples Evaluated (Vessels): N=255**
Right 129
Left 126

True Negative (<50%)
Right 110
Left 115
Total 225

True Positive (>50%)
Right 13
Left 6
Total 19

False Negative
Right 0
Left 2
Total 2

False Positive
Right 6
Left 3
Total 9

False Positive / Negative Causes
Incorrect Sensor Array Placement 4
Excessive Noise (Internal) 2
Hardware Error 3
Unknown 2
Total 11

Given These Results-
Specificity 225/236 96%
Sensitivity 19/21 90%
Overall Accuracy 244/255 96%

* Patient exclusions (33 vessels): Prior carotid endarterectomy, prior carotid stent, prior neck surgery, severe heart disease.
** Vessels with No Reading (NR) or poor Quality of Placement (QOP) – 38 (Most of these were on Device 7)

CAUTION: FOR INVESTIGATIONAL USE ONLY. This device is not yet cleared or approved for use in humans by the Food and Drug Administration.

About CVR Medical

CVR Medical Corp. is a healthcare company that operates in the medical device industry focused on the commercialization of its disruptive, proprietary CSS Device. The CSS device is a diagnostic tool that encompasses subsonic, infrasonic, and low frequency sound wave analysis technology. The CSS Device is a patented device designed to detect and measure carotid arterial stenosis. CVR is currently in pivotal clinical trials in preparation for its planned submission to the FDA. CVR is led by an experienced and proven team of professionals with extensive healthcare, medical device, international expansion, regulatory and sales experience. CVR Medical trades on the TSX Venture Exchange under the symbol CVM. Additional information regarding the Company can be found in our recent filings with the SEDAR as well as the information maintained on our website at www.cvrmed.com

ON BEHALF OF THE BOARD:
(signed) "Peter Bakema"
CEO, President & Director

For further information contact:
Peter Bakema, CEO, President and Director
Email: info@cvrmed.com
or
Marc S. Lubow.
Vice President Capital Markets, Investor Relations
marclubow@cvrmed.com

This press release contains forward-looking information that involves various risks and uncertainties regarding future events related to the Joint Venture. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements and are not guarantees of future performance of the Company. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. These forward-looking statements reflect management's current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) a downturn in general economic conditions in North America and internationally, (2) the inherent uncertainties and speculative nature associated with commercialization of technology and the practice of medicine, (3) a change in health regulations, (4) any number of events or causes which may delay or cease commercialization and development of the Joint Venture, (5) the risk that the Company or the Joint Venture does not execute its business plan, (6) inability to retain key employees, (7) inability to finance operations and growth, and (8) other factors beyond the Company's control. These forward-looking statements are made as of the date of this news release and, except as required by law, the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.

THE TSX VENTURE EXCHANGE INC. HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS PRESS RELEASE. NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Peter Bakema
CVR Medical Corp.
734-718-5115
email us here

Source: EIN Presswire